Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin
Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 1
Abstract
The aim of the study was to characterize the platelet count (PLT) dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal oxaliplatin (HIO). Data from patients treated with CRS alone (N = 18) or CRS and HIO (N = 62) were used to estimate the baseline platelet count (PLT0), rate constants for platelet maturation (ktr) and platelet random destruction (ks), feedback on progenitor cell proliferation (γ), and the drug-specific model parameters (α, β). Plasma oxaliplatin concentrations, Cp, reduced the proliferation rate of progenitor cells (kprol) according to a power function α × Cpβ. The surgery effect on kprol and ks was explored. The typical values (between subject variability) of the PLT0, ktr, ks, γ, α, and β were estimated to be 237 × 109 cells/L (32.9%), 7.09 × 10−3 h−1 (47.1%), 8.86 × 10−3 h−1 (80.0%), 0.621, 0.88 L/mg (56.9%), and 2.63. Surgery induced a maximal 2.09-fold increase in kprol that was attenuated with a half-life of 8.42 days. Splenectomy decreased ks by 47.5%. Age, sex, body surface area, sex, total proteins, and HIO carrier solution did not impact the model parameters. The model developed suggests that, following CRS and HIO, thrombocytopenia and thrombocytosis were reversible and short-lasting; the severity of the thrombocytopenia and thrombocytosis was inversely correlated, with splenectomized patients having thrombocytopenia of lower severity and thrombocytosis of higher severity; and the HIO dose and treatment duration determine the severity and duration of the thrombocytopenia. Higher HIO dose or longer treatment duration could be used without substantially increasing the risk of major hematological toxicity.
Authors and Affiliations
Carlos Pérez-Ruixo, Belén Valenzuela, José Esteban Peris, Pedro Bretcha-Boix, Vanesa Escudero-Ortiz, José Farré-Alegre, Juan José Pérez-Ruixo
Keywords
Related Articles
- EP ID EP680833
- DOI 10.1208/s12248-015-9839-0
- Views 94
- Downloads 0
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Ophthalmic liposomes of ganciclovir (GCV) were prepared by the reverse phase evaporation method, and their ocular pharmacokinetics in albino rabbits were compared with those obtained after dosing with GCV solution. The i...
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases
Regulator of G-protein signaling (RGS) proteins were originally identified as negative regulators of G-protein-coupled receptor (GPCR) signaling via their GTPase-accelerating protein (GAP) activity. All RGS proteins cont...
Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material
The purpose of this study was to assess the potential use of poly(ethylene oxide) (PEO) as matrix-forming mate-rial for tablets and extrudates. Raw materials were characterized for size, size distribution, and shape. Tab...
On Average: Data Exploration Based on Means Can Be Misleading
The following is an extract from the NONMEM® code used to fit Eq. 20 to the data.
Stochastic Process Pharmacodynamics: Dose Timing in Neonatal Gentamicin Therapy as an Example
The online version of this article (doi:10.1208/s12248-014-9715-3) contains supplementary material, which is available to authorized users.